Overview
Twenty years after KBP-2000-CPHG study and ten years after KBP-2010-CPHG study, the CPHG proposes to conduct a new epidemiological study on primary PLC in order to evaluate and analyze the changes that have occurred over the last decade.
Primary endpoint:
Estimate 1-year- and 5-year-mortality rates in patients with PLC.
Secondary endpoints:
- Describe PLC patient population managed by pulmonologists at French General Hospitals in 2020
- Describe PLC diagnostic and therapeutic management by pulmonologists at French General Hospitals in 2020 and compare them to KBP-2000-CPHG and KBP-2010-CPHG studies
- Estimate prognostic factors
- Compare patient and tumor characteristics to those observed for KBP-2010-CPHG and KBP-2000-CPHG studies
- Compare observed survival rates to those reported for KBP-2000-CPHG and KBP-2010-CPHG studies
Eligibility
Inclusion Criteria:
- Age ≥ 18 years
- Primary Lung Cancer histologically (or cytologically or presence of a mutation on liquid biopsy with compatible imaging) proven between January 1st and December 31st, 2020*
- Follow-up by a lung specialist at a General Hospital
- Oral informed consent * date of collected sample
Exclusion Criteria:
- Age < 18 years
- Secondary lung cancer
- Recurrence of same histological type PLC- left to the investigator discretion according to the clinic and the imagery
- Previous enrolment in the study
- Freedom deprived patient following a legal or administrative decision
- Patient unable to give his(her) consent